Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.3B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Advanced Micro Devices
AMD
|
+$925M |
| 4 |
S&P Global
SPGI
|
+$894M |
| 5 |
Tesla
TSLA
|
+$716M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
XLNX
Xilinx Inc
XLNX
|
+$1.08B |
| 2 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$972M |
| 3 |
Merck
MRK
|
+$295M |
| 4 |
Exelon
EXC
|
+$259M |
| 5 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$205M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.39% |
| 2 | Financials | 13.32% |
| 3 | Healthcare | 13.3% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Transcat
TRNS
$860M
| $9.89M | ﹤0.01% |
121,912
+1,985
| +2% | +$161K |
|
|
QUOT
2352
DELISTED
Quotient Technology Inc
QUOT
| $9.87M | ﹤0.01% |
1,547,356
-364,527
| -19% | -$2.44M |
|
2353
Karyopharm Therapeutics
KPTI
$44.4M
| $9.86M | ﹤0.01% |
89,193
-6,989
| -7% | -$871K |
|
2354
Copa Holdings
CPA
$5.98B
| $9.83M | ﹤0.01% |
117,568
+6,775
| +6% | +$557K |
|
2355
Arcutis Biotherapeutics
ARQT
$3.26B
| $9.81M | ﹤0.01% |
509,381
+20,037
| +4% | +$339K |
|
|
CHS
2356
DELISTED
Chicos FAS, Inc.
CHS
| $9.81M | ﹤0.01% |
2,042,965
+30,343
| +2% | +$142K |
|
|
CANO
2357
DELISTED
Cano Health, Inc.
CANO
| $9.79M | ﹤0.01% |
15,412
+536
| +4% | +$338K |
|
|
TVRD
2358
Tvardi Therapeutics
TVRD
$19M
| $9.78M | ﹤0.01% |
22,351
-1,011
| -4% | -$415K |
|
|
VERV
2359
DELISTED
Verve Therapeutics
VERV
| $9.73M | ﹤0.01% |
426,268
+135,800
| +47% | +$3.88M |
|
2360
TPG
TPG
$7.86B
| $9.72M | ﹤0.01% |
+322,497
| New | +$9.97M |
|
2361
Latham Group
SWIM
$669M
| $9.7M | ﹤0.01% |
732,870
+223,183
| +44% | +$3.71M |
|
2362
American Vanguard Corp
AVD
$71.2M
| $9.7M | ﹤0.01% |
477,442
+20,586
| +5% | +$337K |
|
2363
PetMed Express
PETS
$42.5M
| $9.68M | ﹤0.01% |
375,366
+29,303
| +8% | +$760K |
|
|
FBRT
2364
Franklin BSP Realty Trust
FBRT
$639M
| $9.68M | ﹤0.01% |
692,658
+6,452
| +0.9% | +$88.2K |
|
|
CHUY
2365
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $9.67M | ﹤0.01% |
358,303
+10,781
| +3% | +$299K |
|
2366
Solid Power
SLDP
$517M
| $9.67M | ﹤0.01% |
1,115,671
+987,787
| +772% | +$7.67M |
|
2367
Theravance Biopharma
TBPH
$875M
| $9.66M | ﹤0.01% |
1,010,163
-31,669
| -3% | -$310K |
|
|
HAYN
2368
DELISTED
Haynes International, Inc.
HAYN
| $9.64M | ﹤0.01% |
226,316
+6,304
| +3% | +$248K |
|
|
RYZ
2369
Ryerson Holding Corp
RYZ
$1.4B
| $9.61M | ﹤0.01% |
274,301
-2,744
| -1% | -$74.7K |
|
|
EQRX
2370
DELISTED
EQRx, Inc. Common Stock
EQRX
| $9.6M | ﹤0.01% |
2,325,144
+2,237,082
| +2,540% | +$9.74M |
|
2371
Select Water Solutions
WTTR
$2.3B
| $9.59M | ﹤0.01% |
1,119,231
+33,855
| +3% | +$264K |
|
2372
The RMR Group
RMR
$325M
| $9.57M | ﹤0.01% |
307,839
+2,411
| +0.8% | +$75.3K |
|
2373
IDT Corp
IDT
$1.67B
| $9.56M | ﹤0.01% |
280,597
-58,876
| -17% | -$2.19M |
|
|
FIRY
2374
Firy Inc
FIRY
$146M
| $9.55M | ﹤0.01% |
159,215
+1,624
| +1% | +$132K |
|
2375
Franklin Covey
FC
$244M
| $9.54M | ﹤0.01% |
210,983
+4,177
| +2% | +$194K |
|
Similar funds
Geode Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, Geode Capital Management held 5,100 positions worth $801B, down 3.5% from $830B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Geode Capital Management's Q1 2022 filing shows 137 new, 3,082 increased, 1,102 reduced and 125 closed positions. Its largest new stake was Constellation Energy: 5,541,478 shares worth $311M. The largest sale was Xilinx Inc, an estimated $1.08B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q1 2022 buy was Constellation Energy: 5,541,478 shares worth $311M.
- Geode Capital Management added most to Apple in Q1 2022, an estimated $1.3B increase.
- Geode Capital Management's biggest Q1 2022 reduction was Merck, cutting an estimated $295M.
- Geode Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $1.08B.
- Geode Capital Management's ten largest holdings make up 24% of its $801B portfolio in Q1 2022.
- Geode Capital Management opened 137 new positions and closed 125 in Q1 2022.
- Geode Capital Management's portfolio value fell 3.5% quarter-over-quarter to $801B.
Based on Geode Capital Management's 13F filing for Q1 2022, filed 13 May 2022.